Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Lung Neoplasms 19Melanoma 18Neoplasm Metastasis 16Carcinoma, Hepatocellular 15Neoplasms 13Esophageal Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Colorectal Neoplasms 9Breast Neoplasms 9Head and Neck Neoplasms 8Stomach Neoplasms 6Rectal Neoplasms 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Renal Cell 6Brain Neoplasms 6Small Cell Lung Carcinoma 5Recurrence 5Pancreatic Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Liver Neoplasms 4Glioblastoma 4Cholangiocarcinoma 4Prostatic Neoplasms 3Nasopharyngeal Carcinoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3

Interventions

Diathermy 22Radiotherapy 11Drug Therapy 5Cisplatin 5Fluorouracil 4Radiation 3Melphalan 3Immune Checkpoint Inhibitors 3Cytoreduction Surgical Procedures 3Brachytherapy 3tislelizumab 2Surgical Procedures, Operative 2Solutions 2Immunotherapy 2Hyperthermia, Induced 2Hydrogen Peroxide 2Doxorubicin 2Conization 2Capecitabine 2spartalizumab 1sodium thiosulfate 1anlotinib 1Therapeutics 1Temozolomide 1Saline Solution 1Radiation Dose Hypofractionation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hyperthermia × Immunotherapy × Clear all
NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

China Medical University, China

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Zhejiang Hospital

Phase 2 Recruiting
60 enrolled

Hyperthermia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡